Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 9, 2006, Pages 847-854

  Shiff, Clive ^a   Veltri, Robert ^b   Naples, Jean ^a   Quartey, Joseph ^c   Otchere, Joseph ^c   Anyan, William ^c   Marlow, Cameron ^b   Wiredu, Edwin ^d   Adjei, Andrew ^d   Brakohiapa, Edmond ^d   Bosompem, Kwabena ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Ghana   (Ghana)

^d UNIVERSITY OF GHANA   (Ghana)

Author keywords

Age prevalence; Bladder damage; BLCA 4; Ghana; Nuclear morphometrics; Schistosoma haematobium

Indexed keywords

BIOLOGICAL MARKER; BLCA 4 PROTEIN; DNA; NUCLEAR MATRIX PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BLADDER INJURY; CANCER INCIDENCE; CASE CONTROL STUDY; CASE STUDY; CELL NUCLEUS; CELL STRUCTURE; CHRONIC DISEASE; CONTROLLED STUDY; CYSTOSCOPY; CYTOPATHOLOGY; DISEASE SEVERITY; ECHOGRAPHY; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; EPITHELIUM CELL; GEOGRAPHIC DISTRIBUTION; GHANA; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PLOIDY; PREVALENCE; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; RURAL POPULATION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SQUAMOUS CELL METAPLASIA; URINALYSIS; URINARY TRACT INFECTION; URINE SEDIMENT;

ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; CHRONIC DISEASE; ENDEMIC DISEASES; EPITHELIAL CELLS; FEMALE; GHANA; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POPULATION SURVEILLANCE; PREVALENCE; RURAL HEALTH; SCHISTOSOMIASIS HAEMATOBIA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

EID: 33745628062     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.10.010     Document Type: Article

References (37)

1. Bosompem K.M., Ayi I., Anyan W.K., Arishima T., Nkrumah F.K., and Kojima S. A monoclonal antibody-based dipstick assay for diagnosis of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 554-556
2. Clarke V., Shiff C.J., and Blair D.M. Control of the snail hosts of bilharziasis and fascioliasis in Southern Rhodesia. Bull. World Health Organ. 25 (1961) 549-558
3. Colbourne M., Edington G.M., and Hughes M. A medical survey of a Gold Coast village. Trans. R. Soc. Trop. Med. Hyg. 44 (1950) 271-290
4. Dey P. Urinary markers of bladder carcinoma. Clin. Chim. Acta 340 (2004) 57-65
5. Dimmette R.M., Sproat H.F., and Sayegh E.S. The classification of carcinoma of the urinary bladder associated with schistosomiasis and metaplasia. J. Urol. 75 (1956) 680-686
6. Edington G.M. Malignant disease in the Gold Coast. Br. J. Cancer 10 (1956) 595-608
7. Eissa S., Labib R.A., Mourad M.S., Kamel K., and El Ahmady O. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer. Eur. Urol. 44 (2003) 687-694
8. Eissa S., Ahmed M.I., Said H., Zaghool A., and El-Ahmady O. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life 56 (2004) 557-564
9. Elem B., and Purohit R. Carcinoma of the urinary bladder in Zambia. A quantitative estimation of Schistosoma haematobium infection. Br. J. Urol. 55 (1983) 275-278
10. Esrig D., McEvoy K., and Bennett C.J. Bladder cancer in the spinal cord-injured patient with long-term catheterization: a causal relationship?. Semin. Urol. 10 (1992) 102-108
11. Farrow G.M. Urine cytology in the detection of bladder cancer: a critical approach. J. Occup. Med. 32 (1990) 817-821
12. Ferguson A.R. Associated bilharziasis and primary malignant disease of the urinary bladder, with observations on a series of forty cases. J. Pathol. Bacteriol. 16 (1911) 76-94
13. Gelfand M., Weinberg R.W., and Castle W.M. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1 (1967) 1249-1251
14. Hirata M., Hirata K., Kage M., Zhang M., Hara T., and Fukuma T. Effect of nitric oxide synthase inhibition on Schistosoma japonicum egg-induced granuloma formation in the mouse liver. Parasite Immunol. 23 (2001) 281-289
15. Hodder S.L., Mahmoud A.A., Sorenson K., Weinert D.M., Stein R.L., Ouma J.H., Koech D., and King C.H. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 63 (2000) 133-138
16. King C.L., Malhotra I., Mungai P., Wamachi A., Kioko J., Muchiri E., and Ouma J.H. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-α and diminished interleukin-10 production. J. Infect. Dis. 184 (2001) 1176-1182
17. King C.H., Dickman K., and Tisch D.J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365 (2005) 1561-1569
18. Kitinya J.N., Lauren P.A., Eshleman L.J., Paljivari L., and Tanaka K. The incidence of squamous and transitional cell carcinomas of the urinary bladder in northern Tanzania in areas of high and low levels of Schistosoma haematobium infection. Trans. R. Soc. Trop. Med. Hyg. 80 (1986) 935-939
19. Konety B.R., and Getzenberg R.H. Urine based markers of urological malignancy. J. Urol. 165 (2001) 600-611
20. Konety B.R., Nguyen T., Brenes G., Sholder A., Bastacky S., Potter D., and Getzenberg R. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J. Urol. 164 (2000) 634-639
21. Konety B.R., Nguyen T.-S., Dhir R., Day R.S., Becich M.J., Stadler W.M., and Getzenberg R.H. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin. Cancer Res. 6 (2000) 2618-2625
22. Koss L.G., Deitch D., Ramanathan R., and Sherry S. Diagnostic value of cytology of voided urine. Acta Cytol. 29 (1985) 810-816
23. Landis S.H., Murray T., Bolder S., and Wingo P.A. Cancer statistics. CA Cancer J. Clin. 48 (1998) 6-29
24. Makar N. Some urological aspects of haematobiasis. Egypt J. Bilharz. 1 (1974) 55-64
25. Medhat A., Zazour A., Nafeh M., Shata T., Sweifie Y., Attia M., Helmy A., Shehat M., Zaki S., Mikhail N., Ibrahim S., King C., and Strickland G.T. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 57 (1997) 16-19
26. Mostafa M., Sheweita S.O.P., and O'Connor P.J. Relationship between schistosomiasis and bladder cancer. Clin. Microbiol. Rev. 12 (1999) 97-111
27. Murphy W.M. AFIP Atlas of Tumor Pathology, Series III. Tumors of the kidney and bladder (1994), Armed Forces Institute of Pathology, Washington DC
28. Prates M.D., and Gilman J. Carcinoma of the urinary bladder in Portuguese East Africa with special reference to bilharzial cystitis and preneoplastic reactions. S. Afr. J. Med. Sci. 24 (1959) 13-27
29. Rosin M.P., and Anwar W. Chromosomal damage in urothelial cells from Egyptians with chronic Schistosoma haematobium infections. Int. J. Cancer 50 (1992) 539-543
30. Thomas J.E., Bassett M.T., Signola L.B., and Taylor P.T. Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 551-553
31. Van Le T.S., Myers J., Konety B.R., Barder T., and Getzenberg R.H. Functional characterization of the bladder cancer marker BLCA-4. Clin. Cancer. Res. 10 (2004) 1384-1389
32. Veltri R.W., Partin A.W., and Miller M.C. Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations. J. Cell Biochem. Suppl. 35 (2000) 151-157
33. Veltri R.W., Partin A.W., and Miller M.C. Quantitative nuclear grade: clinical applications of the quantitative measurement using image analysis. In: Kelloff G.J., Hawk E., and Sigman C. (Eds). Cancer Chemoprevention, Vol. 2: Strategies for Cancer Chemoprevention (2004), Humana Press, Totowa, NJ 97-108
34. Weber M.D., Blair D.M., and Clarke V.V. The pattern of schistosome egg distribution in a micturition flow. Cent. Afr. J. Med. 13 (1967) 75-88
35. WHO, 1991. Meeting on Ultrasonography in Schistosomiasis: Proposal for a Practical Guide to the Standardized Use of Ultrasound in Assessment of Pathological Changes. World Health Organization, Geneva, TDR/SCH/Ultrason/91.3.
36. WHO, 2000. Ultrasound in schistosomiasis. A practical guide to the standardized use of ultrasonography for assessment of schistosomiasis-related morbidity. World Health Organization, Geneva, TDR/STR/SCH/00.1.
37. Wojcik E.M., Milller M.C., O'Dowd G., and Veltri R. Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low grade and high grade transitional cell carcinoma. Anal. Quant. Cytol. Histol. 20 (1998) 69-76